This is a brief overview of the entire pharmaceutical industry. It includes an examination of the financial records of 14 of the world’s largest pharmaceutical companies over an 11 year period
“…went over records of 14 of these major pharmaceutical companies, going back 11 years 2003 to 2013…$4.44 Trillion in Revenue…$735 Billion on research…$1.3 Trillion on marketing…their profits, $853 Billion…”
“vaccine paradigm…so many children that have been harmed, that to back away from the paradigm at this time, would be a disaster financially for these people[pharma]”
Residents of Maui County in Hawaii, frequently referred to as ‘GMO Ground Zero,’ claimed a victory Tuesday evening when a measure to ban the planting of genetically modified organisms (GMOs) passed with 50.2 percent.
Agribusiness giants Monsanto and Dow AgroSciences, which for decades have run enormous growing and testing operations on the island, spent nearly $8 million dollars to defeat the ban, making it the most expensive campaign in Hawaii’s history, according to Honolulu Civil Beat.
Top 10 best-selling vaccines of 2013
May 29, 2014
The vaccine market has long been dominated by the Big 3-
– Sanofi ($SNY)
– Merck ($MRK)
– GlaxoSmithKline ($GSK)
-with Pfizer ($PFE) and Novartis ($NVS) trailing the trio on the list of revenue-generators. But things are changing at the top.
List of vaccine Companies by location
“Molecular farming” has seen vaccines, mammalian blood constituents, enzymes, antibodies and low calorie sweeteners produced in tobacco leaves. Australian scientists have engineered a measles gene into tobacco. They are now modifying rice with the gene as an alternative vehicle for vaccines in the developing world where refrigeration of traditional vaccines is difficult.
Scientists have created the ultimate GM crop: contraceptive corn. Waiving fields of maize may one day save the world from overpopulation.
The pregnancy prevention plants are the handiwork of the San Diego biotechnology company Epicyte, where researchers have discovered a rare class of human antibodies that attack sperm.
The main thing holding back large-scale development of effective treatments and vaccines for Ebola to this point is the fact that the return on investment of doing so – the saving of human lives aside – has been a challenging one for private industry to wrap its head around. For one, there’s no chance of a Lipitor-like success. There is no retail market for such drugs, just as there wasn’t for pandemic flu vaccine in 2009. What’s more, governments and non-governmental organizations are pretty much the only buyers around
“Once the government gets into this business, it’s responsible for maintaining what they call ‘warm capacity’,” Kantor says. “Hypothetically, if they want to stockpile 2 million doses of vaccine with the ability to scale to 20 million, they can’t buy the drug once and let the company go bankrupt.” It’s always going to be harder for drug companies to convince themselves of the relative merits of investing in a once-every-fifteen-years virus like Ebola versus funding research into lowering cholesterol levels. But from this point forth, there’s a market for Ebola drugs.
The Weifang Lakeland Safety Products factory in the eastern Shandong province city of Anqui has 100 workers assembling the now-familiar plastic suits at a rate of about 6,000 per day. The factory plans to double its capacity by January.
The ChemMAX and MicroMAX protective suits, made of polyethylene and polypropylene, are produced for the U.S.-based Lakeland Industries, a main supplier of suits in the Ebola outbreak.
Shade exposes the true power structure embedded in our global reality, showing the true controllers their plans to Geo-engineer our planet and control the populace.
Continue reading SHADE the Motion Picture – Shade exposes the true power structure